Damora Therapeutics (DMRA) Amortizatization of Intangibles (2019 - 2026)
Damora Therapeutics posted quarterly Amortizatization of Intangibles of $63000.0 for Q1 2026, up 2000.0% year-on-year from $3000.0 in Q1 2025, and up 6200.0% on a QoQ basis from $1000.0 in Q4 2025.
Damora Therapeutics (DMRA) has 8 years of Amortizatization of Intangibles data on file, last reported at $63000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 2000.0% year-over-year to $63000.0; the trailing twelve-month figure through Mar 2026 stood at $72000.0 (up 191.14% YoY), and the FY2025 full-year result was $12000.0, up 117.14% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $63000.0, up from $1000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $743000.0 in Q3 2022 and bottomed at -$871000.0 in Q4 2022.
- The 5-year median for Amortizatization of Intangibles is $18500.0 (2023), against an average of -$8125.0.
- The widest annual swing landed in 2024, when Amortizatization of Intangibles slumped 213.53%; it then surged 2000.0% in 2026.
- A 5-year view of Amortizatization of Intangibles shows it stood at -$871000.0 in 2022, then surged by 102.87% to $25000.0 in 2023, then tumbled by 1040.0% to -$235000.0 in 2024, then soared by 100.43% to $1000.0 in 2025, then soared by 6200.0% to $63000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $63000.0 (Q1 2026), $1000.0 (Q4 2025), and $5000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Damora Therapeutics | 853.36 Mn | 650.97 Mn | - | 63,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63,000.00 |
| Mar 31, 2026 | 63,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Sep 30, 2024 | -235,000.00 |
| Sep 30, 2024 | -235,000.00 |
| Jun 30, 2024 | 153,000.00 |
| Jun 30, 2024 | 153,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Dec 31, 2023 | 25,000.00 |
| Dec 31, 2023 | 25,000.00 |
| Sep 30, 2023 | 207,000.00 |
| Sep 30, 2023 | 207,000.00 |
| Jun 30, 2023 | 78,000.00 |
| Jun 30, 2023 | 78,000.00 |
| Mar 31, 2023 | 121,000.00 |
| Mar 31, 2023 | 121,000.00 |
| Dec 31, 2022 | -871,000.00 |
| Dec 31, 2022 | -871,000.00 |
| Sep 30, 2022 | 743,000.00 |
| Sep 30, 2022 | 743,000.00 |
| Jun 30, 2022 | -548,000.00 |
| Jun 30, 2022 | -548,000.00 |
| Mar 31, 2022 | 110,000.00 |
| Mar 31, 2022 | 110,000.00 |
| Dec 31, 2021 | 1.15 Mn |
| Dec 31, 2021 | 1.15 Mn |
| Sep 30, 2021 | -497,000.00 |
| Sep 30, 2021 | -497,000.00 |
| Jun 30, 2021 | -331,000.00 |
| Jun 30, 2021 | -331,000.00 |
| Mar 31, 2021 | 97,000.00 |
| Mar 31, 2021 | 97,000.00 |
| Dec 31, 2020 | 52,000.00 |
| Dec 31, 2020 | 52,000.00 |
| Sep 30, 2020 | 82,000.00 |
| Sep 30, 2020 | 82,000.00 |
| Jun 30, 2020 | 29,000.00 |
| Jun 30, 2020 | 29,000.00 |
| Mar 31, 2020 | 25,000.00 |
| Mar 31, 2020 | 25,000.00 |
| Dec 31, 2019 | 30,000.00 |
| Dec 31, 2019 | 30,000.00 |